Explore insights, news, and background stories from the Greater Zurich Area – one of Europe’s most advanced business and innovation hubs. This is where international companies, tech pioneers, and investors find the latest updates on artificial intelligence, robotics, biotech, fintech, and more. Whether you're looking for real-world expansion cases, startup success stories, or key developments in Switzerland’s business environment, our articles offer firsthand perspectives and strategic guidance.
Pharvaris successfully concludes Phase I study
Zug – The most promising drug candidate from Pharvaris to treat hereditary angioedema is safe and tolerated. This was the key finding from the recently concluded clinical Phase I study. Pharvaris is now planning to initiate a Phase II study before the end of the year in addition to conducting an IPO in the USA.
Microsoft investing in Climeworks
Zurich - Climeworks has developed a technology that allows CO2 to be filtered out of the atmosphere. Microsoft is now supporting the construction of a plant for this purpose based in Iceland. Moreover, the IT giant will become a client of Climeworks.
Biotechs receive most venture capital
Investments in Swiss startups were down over 7 percent in 2020. At the same time, domestic biotech startups managed to secure significantly more funding than in the previous year. These are findings of the Swiss Venture Capital Report.
USI Startup Center repositions itself
Lugano – The new Ticino center for the promotion of startups will make the East Campus Lugano its home. This was a strategic choice for proximity to the Informatics and Biomedical Sciences faculties at the Università della Svizzera italiana (USI) and to the innovative technologies of the University of Applied Sciences and Arts of Southern Switzerland (SUPSI).
Venture Kick looks back on successful year
Schlieren ZH – Startups enjoying support from venture capitalist Venture Kick received a total of 724 million Swiss francs last year, despite the coronavirus pandemic. What’s more, they created over 1,000 new jobs.
New funding enables Microcaps to prepare for market
Zurich – Microcaps has raised 5 million Swiss francs in a seed financing round. The startup has developed a method to manufacture microcapsules for the fields of pharmaceuticals, nutrition and cosmetics. It will now be able to commercialize its product.
Mirai Foods secures funds for cultivated meat
Wädenswil ZH – Mirai Foods is set to commercialize earlier than anticipated: the startup from the Greater Zurich Area has raised US$2.4 million in a first tranche of seed financing. It is now preparing to transform its prototype of slaughter-free meat into a commercial product.
Institute develops double antibody against COVID-19
Bellinzona – Researchers at the Institute for Research in Biomedicine have managed to combine two antibodies against COVID-19 into a single entity. This double antibody not only offers reliable protection against the coronavirus and all known variants, but also prevents it from mutating further.
Quercis Pharma licenses key patents
Zug - Quercis Pharma has concluded an exclusive, worldwide licensing agreement for two patents. This expands the patent to cover its drug candidate aimed at treating venous thromboembolism, cancer tumor metastasis and acute respiratory problems in COVID-19 patients.
Meet with an expansion expert
Is Greater Zurich on your expansion radar? We support you on every step of your expansion journey - from location evaluation to fact finding visits.
Our services are free of charge and include:
- Introduction to key contacts in industry, academia, and government
- Location evaluation support to find the ideal base for your business
- Advice on regulatory framework, taxes, labor, market, and setting up a company
- Custom-made fact-finding visits, including office and co-working space
- And much more, customized to meet your needs.